Attovia Therapeutics, Inc. Common Stock (ATTO) — Net Asset Quality Index
Attovia Therapeutics, Inc. Common Stock (ATTO) has a Net Asset Quality Index of 87.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $128.35 Million minus total liabilities of $15.58 Million yields net assets of $112.77 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Attovia Therapeutics, Inc. Common Stock for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Attovia Therapeutics, Inc. Common Stock Net Asset Quality Index Over Time (2024–2025)
This chart shows how Attovia Therapeutics, Inc. Common Stock's Net Asset Quality Index has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the index stands at 87.9%, representing net assets of $112.77 Million against total assets of $128.35 Million USD. For live market cap and overall valuation, see Attovia Therapeutics, Inc. Common Stock stock valuation.
Annual Net Asset Quality Index for Attovia Therapeutics, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Net Asset Quality Index for Attovia Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Attovia Therapeutics, Inc. Common Stock (ATTO) net assets for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 90.9% | $150.79 Million | $165.89 Million | $15.10 Million | ▲ +9.9 pp |
| 2024 | 81.0% | $62.13 Million | $76.72 Million | $14.59 Million | — |